Biotechnology Fights HAI

Biotechnology Fights HAI

illnesses that are most commonly acquired in hospital settings are a formidable foe, but biotech is ready, as this article details.


Superbug Raises Device and Facility HAI Concerns

Superbug Raises Device and Facility HAI Concerns

In terms of prevention for healthcare associated infections (HAI), it’s notable that the market for facillity sterilization is just over 3.1 billion dollars but the market to treat them is much larger at 10 billion. Ideally, the market for treatment should shrink as prevention grows. This may happen, and prevention may become more of a focus now, with the recent superbug concern at UCLA Medical Center. 180 patients may have been exposed to a CRE (carbapenem-resistant enterobacteriaceae) threat, ...